Literature DB >> 3436344

Para-hydroxytranylcypromine: presence in rat brain and heart following administration of tranylcypromine and an N-cyanoethyl analogue.

A J Nazarali1, G B Baker, R T Coutts, A J Greenshaw.   

Abstract

para-Hydroxytranylcypromine (p-OHTCP) has recently been unequivocally identified in our laboratory as a metabolite of the antidepressant tranylcypromine (TCP). In the study reported here, we have determined brain and heart levels of p-OHTCP in the rat after intraperitoneal administration of a 0.1 mmol/kg dose of TCP or N-(2-cyanoethyl)tranylcypromine (CE-TCP). The animals were killed at 5, 15, 30, 60, 120 or 240 min after drug administration and the tissues (brain and heart) rapidly dissected out. The tissues were frozen in isopentane on solid carbon dioxide and stored at -20 degrees C until time of analysis. Tissue levels of p-OHTCP, TCP and CE-TCP were determined after aqueous pentafluorobenzoylation by conducting analyses with a gas-liquid chromatograph equipped with a fused silica (SE-54) capillary column and an electron-capture detector. Our results show that substantial concentrations of p-OHTCP were present in both brain and heart after TCP and CE-TCP administration. Higher levels of p-OHTCP were present in the brain than in the heart after TCP treatment, but this situation was reversed with the CE-TCP-treated rats. Since p-OHTCP has been shown to retain some MAO-inhibiting properties and to have effects on uptake of catecholamines and serotonin it could therefore contribute to the pharmacological profile of TCP.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3436344     DOI: 10.1007/BF03189899

Source DB:  PubMed          Journal:  Eur J Drug Metab Pharmacokinet        ISSN: 0378-7966            Impact factor:   2.441


  11 in total

1.  Urinary excretion of phenolic metabolites of N-(n-propyl)amphetamine in man.

Authors:  R T Coutts; G W Dawson
Journal:  Res Commun Chem Pathol Pharmacol       Date:  1977-06

2.  Comparison of the apparent antidepressant activity of (-) and (+) tranylcypromine in an animal model.

Authors:  J A Fuentes; M A Oleshansky; N H Neff
Journal:  Biochem Pharmacol       Date:  1976-04-01       Impact factor: 5.858

3.  Detection and quantitation of a ring-hydroxylated metabolite of the antidepressant drug tranylcypromine.

Authors:  G B Baker; D R Hampson; R T Coutts; R G Micetich; T W Hall; T S Rao
Journal:  J Neural Transm       Date:  1986       Impact factor: 3.575

4.  The influence of replacement of the N-ethyl group by the cyanoethyl group on the absorption, distribution and metabolism of (plus or minus)-ethylamphetamine in man.

Authors:  A H Beckett; E V Shenoy; J A Salmon
Journal:  J Pharm Pharmacol       Date:  1972-03       Impact factor: 3.765

5.  [Clinical experimentation with fenproporex in the treatment of obesity. Apropos of 40 cases].

Authors:  H Warembourg; J Jaillard
Journal:  Lille Med       Date:  1968-03

6.  A method for measurement of tranylcypromine in rat brain regions using gas chromatography with electron capture detection.

Authors:  D G Calverley; G B Baker; R T Coutts; W G Dewhurst
Journal:  Biochem Pharmacol       Date:  1981-04-15       Impact factor: 5.858

7.  [Treatment of obese female patients with fenproporex within the framework of gynecologic practice].

Authors:  G Hertel; W Fallot-Burghardt
Journal:  Fortschr Med       Date:  1978-12-14

8.  Amphetamine in rat brain after intraperitoneal injection of N-alkylated analogues.

Authors:  A J Nazarali; G B Baker; R T Coutts; F M Pasutto
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  1983       Impact factor: 5.067

9.  N-(2-cyanoethyl)tranylcypromine, a potential prodrug of tranylcypromine: its disposition and interaction with catecholamine neurotransmitters in brain.

Authors:  A J Nazarali; G B Baker; R T Coutts; T F Wong
Journal:  Pharm Res       Date:  1987-02       Impact factor: 4.200

10.  Metabolism and disposition of N-(2-cyanoethyl)amphetamine (fenproporex) and amphetamine: study in the rat brain.

Authors:  R T Coutts; A J Nazarali; G B Baker; F M Pasutto
Journal:  Can J Physiol Pharmacol       Date:  1986-06       Impact factor: 2.273

View more
  4 in total

Review 1.  Neurochemical and metabolic aspects of antidepressants: an overview.

Authors:  G B Baker; R T Coutts; A J Greenshaw
Journal:  J Psychiatry Neurosci       Date:  2000-11       Impact factor: 6.186

Review 2.  Insights into the mechanisms of action of the MAO inhibitors phenelzine and tranylcypromine: a review.

Authors:  G B Baker; R T Coutts; K F McKenna; R L Sherry-McKenna
Journal:  J Psychiatry Neurosci       Date:  1992-11       Impact factor: 6.186

Review 3.  Metabolism of monoamine oxidase inhibitors.

Authors:  G B Baker; L J Urichuk; K F McKenna; S H Kennedy
Journal:  Cell Mol Neurobiol       Date:  1999-06       Impact factor: 5.046

4.  Cytochrome P450 1A2 Is Incapable of Oxidizing Bilirubin Under Physiological Conditions.

Authors:  Xinyi Li; Dongzhen Yu; Huiqun Jie; Huiqun Zhou; Haibo Ye; Guo Ma; Lili Wan; Chunyan Li; Haibo Shi; Shankai Yin
Journal:  Front Pharmacol       Date:  2019-10-18       Impact factor: 5.810

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.